G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $154,000 | -38.6% | 11,461 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $251,000 | -77.3% | 11,461 | -75.1% | 0.00% | -80.0% |
| Q1 2021 | $1,108,000 | -47.9% | 46,046 | -61.1% | 0.01% | -44.4% |
| Q4 2020 | $2,128,000 | +31.9% | 118,311 | -15.3% | 0.01% | +28.6% |
| Q3 2020 | $1,613,000 | -45.2% | 139,651 | +15.1% | 0.01% | -50.0% |
| Q2 2020 | $2,944,000 | +336.8% | 121,360 | +98.3% | 0.01% | +250.0% |
| Q1 2020 | $674,000 | +31.1% | 61,191 | +214.8% | 0.00% | +33.3% |
| Q4 2019 | $514,000 | – | 19,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
| CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
| Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
| Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
| Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
| Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
| Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
| Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |